Related by context. All words. (Click for frequent words.) 81 HRQoL 81 HRQL 79 QoL 71 psychosocial functioning 71 EQ 5D 71 neurocognitive function 70 symptom severity 70 depressive symptomatology 70 SGRQ 69 QOL 69 subscales 68 subscale scores 68 psychiatric comorbidity 68 sociodemographic characteristics 67 somatic symptoms 67 EORTC QLQ C# 67 Health Assessment Questionnaire 66 depressive symptoms 66 psychiatric morbidity 66 Depressive symptoms 66 psychopathological symptoms 66 neurocognitive functioning 66 psychiatric comorbidities 66 alexithymia 65 biochemical recurrence 65 serum lipid levels 65 MMSE score 65 comorbidity 65 MMSE scores 65 WOMAC pain 65 comorbid conditions 65 sociodemographic factors 64 erection hardness 64 LUTS 64 posttreatment 64 euthymic 64 premorbid 64 logistic regression analyzes 64 posttransplant 64 Mental Component 64 BMI z 64 psychosocial variables 64 IBDQ 64 nondepressed 64 autonomic dysfunction 64 univariate analyzes 64 SF #v# 64 adenotonsillectomy 64 NIH CPSI 64 Logistic regression analysis 64 enthesitis 64 comorbid depression 63 oncologic outcomes 63 multivariate analyzes 63 Montgomery Åsberg Depression 63 neurodevelopmental outcome 63 WOMAC scores 63 CORE OM 63 postoperative mortality 63 tumor histology 63 multivariable analysis 63 covariate 63 MetS 63 convergent validity 63 subclinical atherosclerosis 63 Outcomes Study 63 function subscale 63 androgen deficiency 63 Symptom severity 63 carotid IMT 63 GH deficiency 63 euthymic patients 63 affective disorders 63 comorbid 62 multiple logistic regression 62 cardio respiratory fitness 62 subscore 62 suicide attempters 62 APOE genotype 62 subscores 62 comorbid anxiety 62 WOMAC 62 Comorbidity 62 acetabular dysplasia 62 liver histology 62 chronicity 62 depressive symptom 62 exploratory endpoints 62 serum PTH 62 logistic regression model 62 NIHSS score 62 cognitive affective 62 inflammatory biomarkers 62 interobserver 62 salivary cortisol 62 International Prostate Symptom 62 psychometric properties 62 HAM D# 62 Suicidal ideation 62 OAB symptoms 62 affective psychoses 62 daytime somnolence 62 T2DM 61 metabolic parameters 61 neuropsychiatric symptoms 61 multivariable analyzes 61 subclinical hypothyroidism 61 cognitive function 61 Symptom Checklist 61 MADRS score 61 urinary symptoms 61 HADS 61 hippocampal volume 61 cardiac autonomic 61 Seattle Angina Questionnaire 61 abdominal adiposity 61 ejaculatory function 61 Secondary endpoints 61 lipid profiles 61 telomere lengths 61 comorbidities 61 Endothelial function 61 metabolite concentrations 61 neuropsychological functioning 61 atrophic gastritis 61 sociodemographic variables 61 neurodevelopmental outcomes 61 Univariate analysis 61 intact parathyroid hormone 61 Multivariate analyzes 61 preoperative PSA 61 systolic function 61 pain subscale 61 HAQ DI 61 meta regression 61 angiographically 61 PsA 61 antioxidant supplementation 61 myocardial viability 61 Unified Parkinson Disease 60 DLQI 60 nasal obstruction 60 perioperative complications 60 symptomatology 60 daytime alertness 60 tryptophan depletion 60 clinically meaningful improvements 60 parkinsonian 60 Sociodemographic 60 multivariate logistic regression 60 IIEF 60 endometrial thickness 60 HDRS 60 neurocognitive impairment 60 dyslipidaemia 60 neurocognition 60 prostate cancer CaP 60 Logistic regression 60 ADCS ADL 60 serum IGF 60 diabetes mellitus DM 60 hip BMD 60 adrenal function 60 ADAS Cog 60 Insulin sensitivity 60 PANSS scores 60 HIV HCV coinfected 60 Incontinence Impact Questionnaire 60 overactive bladder symptoms 60 Neuropsychiatric Inventory NPI 60 Score DAS 60 Global Impression CGI 60 echocardiographic parameters 60 Multiple logistic regression 60 spirometric 60 mucosal inflammation 60 erectile function 60 carotid stenosis 60 ANCOVA 60 radical prostatectomy RP 60 untreated psychosis 60 Brief Psychiatric 60 hypochondriasis 60 shorter telomere length 60 Pain Intensity 60 ADCS CGIC 60 affective psychosis 60 hypertension diabetes mellitus 60 Visual Analog Scale 60 transient elastography 60 clinicopathological features 60 NYHA functional class 60 clinicopathological 60 multivariable adjusted 60 Index CDAI 60 IPAH 60 PANSS 60 serum folate concentrations 60 neuropsychological assessment 60 left ventricular diastolic 60 P = .# 60 Socioeconomic status 60 dietary calcium intake 60 thiopurine 60 coronary calcification 60 comorbid disorders 60 posttest 60 atherogenic dyslipidemia 59 symptom checklist 59 Subgroup analyzes 59 knee OA 59 Montgomery Asberg Depression 59 PSADT 59 histological subtype 59 fasting insulin 59 thyrotropin levels 59 CI #.#-#.# [001] 59 albumin excretion rate 59 bivariate analysis 59 vasomotor 59 intraobserver 59 plasma cortisol 59 preoperative diagnosis 59 intima media thickness 59 comorbid psychiatric disorders 59 airway responsiveness 59 serum selenium 59 interrater reliability 59 Neuropsychiatric Inventory 59 aminotransferases 59 Rating Scale BPRS 59 syndromal 59 dyspareunia 59 UPDRS 59 oxygen desaturation 59 bivariate analyzes 59 anthropometric measures 59 Meta analyzes 59 p = .# [002] 59 serum concentrations 59 obstructive CAD 59 point Likert scale 59 EDSS scores 59 postoperative morbidity 59 radiographic findings 59 neurocognitive deficits 59 leukocyte counts 59 WOMAC TM 59 haematologic 59 colorectal adenoma 59 T1DM 59 HOMA IR 59 Main Outcome Measures 59 poststroke 59 postoperative AF 59 serum estradiol 59 Distress Scale 59 neurosensory 59 nondiabetic patients 59 mRNA expression 59 glycosylated hemoglobin HbA1c 59 LV ejection fraction 59 CVD mortality 59 hsCRP levels 59 RYGB 59 extrapyramidal symptoms 59 #q# deletion syndrome 59 Secondary efficacy endpoints 59 hypogonadal 59 CLBP 59 hypercholesterolaemia 59 androgen deprivation 59 schizophreniform disorder 59 Rating Scale MADRS 59 nonpharmacologic 59 femoral neck BMD 59 DAS# scores 59 tertiles 59 hematologic parameters 59 left ventricular LV 59 analgesic efficacy 59 nonoperative treatment 59 mortality morbidity 59 mRS 59 F FDG PET 59 bacterial prostatitis 59 UPDRS motor 59 somatic complaints 59 Functional Assessment 58 lesional 58 Epworth Sleepiness Scale 58 Multivariate analysis 58 albumin excretion 58 SCr 58 hyperactivity inattention 58 prevalences 58 rheumatoid factor 58 postinjury 58 vesicoureteral reflux 58 hepatic lesions 58 diabetes mellitus hypertension 58 interobserver reliability 58 plain radiographs 58 lowest tertile 58 SLNB 58 Cognitive behavioral 58 dysthymia 58 predictive validity 58 histologic 58 systolic hypertension 58 waist circumference WC 58 parkinsonism 58 Multivariate logistic regression 58 differential gene expression 58 serum parathyroid hormone 58 hydroxyvitamin D levels 58 Visual Analogue Scale VAS 58 histopathological 58 SRBD 58 Apgar scores 58 PSQI 58 clinically meaningful improvement 58 sociodemographics 58 Pearson correlation coefficients 58 conditional logistic regression 58 β blockers 58 Poisson regression 58 intracranial hypertension 58 scintigraphic 58 BPRS 58 tibiofemoral 58 arterial thickening 58 somatoform disorders 58 etiologic 58 prognostic variables 58 Skin sterol 58 elevated creatinine 58 plasma leptin 58 odds ratios ORs 58 Charlson comorbidity index 58 psychiatric outpatients 58 coronary stenosis 58 prognostic indicators 58 posttraumatic 58 urothelial carcinoma 58 IPSS 58 rCBF 58 Negative Syndrome 58 tic severity 58 comorbid psychiatric 58 antidepressant efficacy 58 FACIT 58 pain catastrophizing 58 HNSCC 58 hepatic fibrosis 58 erythrocyte sedimentation rate 58 chronic prostatitis chronic 58 diastolic pressures 58 primary aldosteronism 58 osteochondroma 58 logistic regression analysis 58 serum lipids 58 QIDS SR 58 alanine aminotransferase ALT 58 plasma lipids 58 cognitive functioning 58 bulimia nervosa 58 urinary tract symptoms 58 juvenile idiopathic arthritis JIA 58 prognostic factors 58 Disease Activity 58 elevated triglyceride levels 58 tissue oxygenation 58 % CI #.#-#.# [006] 58 neuropsychological impairments 58 histologic subtype 58 neurocognitive 58 APOE ε4 58 plasma lipid 58 bone scintigraphy 58 osteoarthritic 58 urolithiasis 58 potentially modifiable 58 sociodemographic 58 Oswestry Disability Index 58 polyarticular 58 cerebral perfusion 58 semiquantitative 58 RLS symptoms 58 allostatic load 58 CTEPH 58 serum lipid 58 neurological abnormalities 58 cTnI 58 postoperative complication 58 nulliparous women 58 lymphocyte count 58 Comorbid 58 NNT = 58 habitual snoring 58 randomized controlled trials RCTs 58 univariate analysis 58 clinicopathologic 58 Child Behavior Checklist 58 clinico pathological 58 logistic regression models 58 Histologic 58 Scale Cognitive Subscale 58 pharmacodynamic parameters 58 EDSS score 58 androgen depletion 58 AST ALT 58 Baseline characteristics 58 bivariate 58 metabolic syndrome MetS 58 highest tertile 58 inotropic 58 flow mediated dilation 58 perimenopausal women 58 pulmonary capillary wedge 58 femoral neck fracture 58 LV dysfunction 58 NIHSS 58 urinary N telopeptide 58 SELENA SLEDAI 58 prognostic significance 58 virologic response 58 DHEA supplementation 58 CFQ R 58 androgen suppression 58 percutaneous vertebroplasty 58 PSA nadir 58 Scale PANSS 58 perioperative morbidity 58 dyspnoea 58 impaired cognition 58 decompensated cirrhosis 57 PCWP 57 multivariate adjustment 57 pathologic fractures 57 left ventricular systolic 57 Sjögren syndrome 57 Primary endpoints 57 variceal bleeding 57 plasma homocysteine levels 57 gallstone disease 57 mu opioid 57 Heritability 57 preoperatively 57 abnormal lipid 57 BPS IC 57 cranial irradiation 57 pCR 57 retrospective cohort 57 ADAS cog 57 subthreshold depression 57 covariates 57 mammographic density 57 BMI waist circumference 57 HAMD 57 endothelial function 57 actigraphy 57 HER2 expression 57 serum vitamin D 57 sonographic diagnosis 57 ski lls 57 hepatic cirrhosis 57 fractional anisotropy 57 hyperprolactinemia 57 perinatal outcomes 57 reflux symptoms 57 subtrochanteric 57 CI -#.# 57 hyperhomocysteinemia 57 cerebral oxygenation 57 carotid atherosclerosis 57 histologic findings 57 urinary excretion 57 virological response 57 chi ^ sup 57 generalized estimating 57 salivary flow 57 confidence intervals CIs 57 prospective multicenter study 57 voiding dysfunction 57 Multiple linear regression 57 lifetime abstainers 57 glycated hemoglobin HbA1c 57 % CI #.#-#.# [003] 57 Preoperatively 57 psychophysiological 57 Psoriasis Area 57 interindividual variability 57 hypogonadotropic hypogonadism 57 serum phosphate 57 hippocampal volumes 57 progesterone receptor PR 57 dyssynchrony 57 familial aggregation 57 thromboembolic 57 parous women 57 bronchial hyperresponsiveness 57 Kaplan Meier curve 57 estimated glomerular filtration 57 somatization disorder 57 aminotransferase levels 57 Postoperative 57 parkinsonian symptoms 57 oxycodone CR 57 urodynamic parameters 57 serum testosterone 57 Secondary endpoints include 57 elevated ALT 57 prespecified secondary 57 mitochondrial toxicity 57 pathophysiological mechanisms 57 impaired glucose metabolism 57 symptomatic VTE 57 CHD mortality 57 HbA1c levels 57 SSc 57 airway hyperresponsiveness 57 distensibility 57 Heavy menstrual bleeding 57 haemodynamic 57 CONCERTA ® 57 chronic periodontitis 57 adiposity 57 QTc prolongation 57 Cystatin C 57 diabetic polyneuropathy 57 exhaled nitric oxide 57 physiologic parameters 57 cortisol secretion 57 APACHE II 57 FDG uptake 57 allele frequencies 57 nonpsychotic 57 NAbs 57 plasma creatinine 57 YMRS 57 hyperarousal 57 CIMZIA TM certolizumab pegol 57 morbidity mortality 57 cardiorespiratory fitness 57 Scale EDSS 57 adiponectin concentrations 57 unmeasured confounders 57 psoriatic arthritis PsA 57 sonographic findings 57 serum calcium levels 57 elevated serum creatinine 57 chromium picolinate supplementation 57 ECLS 57 macrovascular disease 57 serum cortisol 57 neuroimaging studies 57 hemodynamic parameters 57 SGPT 57 metabolic dysfunction 57 STEP BD 57 homocysteine concentrations 57 hemodynamics 57 VFQ 57 neurologic impairment 57 Cardiorespiratory fitness 57 amenorrhoea 57 Subgroup analysis 57 chlamydial infection 57 CP CPPS 57 Visual acuity 57 serum albumin 57 serum calcium 57 urinary albumin excretion 57 multivariable logistic regression 57 interpersonal psychotherapy 57 serum markers 57 creatinine ratio 57 corticosteroid dose 57 generalized epilepsy 57 postintervention 57 transferrin saturation 57 dysmenorrhea 57 probiotic supplementation 57 plasma folate 57 mineral density 57 Main Outcome Measure 57 Cognitive impairment 57 troponin T 57 Alzheimer Disease Assessment 57 familial clustering 57 HRCT 57 testosterone supplementation 57 somatization 57 postoperative radiotherapy 57 lymph node metastasis 57 co morbidities 57 multivariate Cox 57 Index FSFI 57 postoperative pulmonary 57 underlying pathophysiology 57 Scale cognitive subscale 57 QRS duration 57 anti Mullerian hormone 57 cortical atrophy 57 onset diabetes mellitus 57 serum PSA 57 serologically active patients 57 pharmacodynamic PD 57 echocardiographic 57 gastric carcinoma 57 pharmacological therapies 57 tertile 56 subclinical cardiovascular disease 56 lumbar disk herniation 56 confounders 56 body habitus 56 hallux valgus 56 bioavailable testosterone 56 Crohn Disease Activity 56 multivessel disease 56 % CI #.#-#.# [004] 56 atopic 56 TEAEs 56 HbA 1c levels 56 euthyroid 56 solifenacin 56 knee osteoarthritis OA 56 subsyndromal 56 LVEF 56 morbidities 56 aetiology 56 β = 56 electroencephalographic 56 afterload 56 intraclass correlation coefficients 56 internalizing disorders 56 DEXA scan 56 Socio demographic 56 juvenile idiopathic arthritis 56 DAS# CRP 56 CPAP adherence 56 prospective longitudinal 56 chronic prostatitis 56 autoimmune thyroid 56 adrenalectomy 56 QTc intervals 56 fasting plasma 56 SSRI SNRI 56 lymphovascular invasion 56 atypical neuroleptics 56 transaminase levels 56 D dimer 56 virologic responses 56 HER2 overexpression 56 Ejection Fraction 56 hamartomas 56 thyroid dysfunction 56 postmenopausal osteoporotic women 56 symptom exacerbation 56 plasma pharmacokinetics 56 2D 4D ratio 56 gadolinium enhanced 56 prolactin levels 56 adnexal mass 56 handgrip strength 56 HPA axis 56 suicide ideation 56 hip resurfacing arthroplasty 56 clomipramine 56 premenopause 56 menopausal symptom 56 hyperglycaemia 56 adenoma recurrence 56 nonobese 56 Multivariate analysis revealed 56 Score IPSS 56 serum retinol 56 liver transplant recipients 56 HbA 1c 56 gastric adenocarcinoma 56 reflux esophagitis 56 tissue perfusion 56 aortic stiffness 56 Venous thromboembolism 56 clinically meaningful reductions 56 diastolic function 56 univariate 56 CLA supplementation 56 subjective sleepiness 56 meta analytic 56 electrophysiologic 56 callous unemotional traits 56 SHBG levels 56 cognitive domains 56 postop 56 macroalbuminuria 56 mIU L 56 behavioral disinhibition 56 Erectile function 56 muscle dysmorphia 56 HbA1C levels 56 pulmonary exacerbations 56 adiponectin levels 56 undergoing radical prostatectomy 56 neurologic complications 56 venous thromboembolic disease 56 Longitudinal studies 56 affective disorder 56 platelet reactivity 56 Sleep disordered breathing 56 atopy 56 pelvic lymphadenectomy 56 gastric cardia 56 IELT 56 longitudinal observational study 56 hypopituitarism 56 non affective psychosis 56 laterality 56 meta analytic review 56 renal cysts 56 plasma triglycerides 56 Outcome Measures 56 elevated LDH 56 LV hypertrophy 56 dysfunctional voiding 56 hypovitaminosis D 56 secondary efficacy endpoint 56 triiodothyronine 56 % Confidence Interval 56 FDG PET imaging 56 manic hypomanic 56 urodynamic 56 serum GGT 56 bladder bowel 56 glomerular filtration rate 56 lipid parameters 56 neurologic outcomes 56 ejection fractions 56 metabolic abnormalities 56 #.#ng/ml 56 intracranial stenosis 56 Depressive Symptoms 56 Expanded Disability Status 56 Fibromyalgia Impact Questionnaire 56 BMD measurements 56 abstinent alcoholics 56 CDAI 56 symptomatic intracerebral hemorrhage 56 CSF biomarkers 56 FDG PET 56 Genetic variants 56 androgenic 56 apnea hypopnea index 56 SUVmax 56 puerperal psychosis 56 glucocorticoid therapy 56 FEV ^ sub 56 hemodilution 56 body fatness 56 daytime sleepiness 56 acetabular fractures 56 HbA 1C 56 CagA 56 autistic traits 56 FeNO 56 glycosylated hemoglobin levels 56 perceptual reasoning 56 gait disturbance 56 alanine aminotransferase 56 thyrotropin 56 N telopeptide 56 overnight polysomnography 56 obstructive coronary artery 56 myocardial function 56 dysthymic disorder 56 T1 weighted images 56 % CI #.#-#.# [008] 56 atherothrombotic disease 56 LAGB 56 vascular reactivity 56 premenstrual syndrome PMS 56 artery stenosis 56 â ‰ ¥ 56 carotid intima media 56 serum sodium 56 non menstrual pelvic 56 inflammatory markers 56 Likert scale 56 comorbid illnesses 56 hematological parameters 56 #OHD 56 logistic regression 56 perfusion abnormalities 56 transvaginal sonography 56 hippocampal atrophy 56 proliferative diabetic retinopathy 56 normotensive 56 Hemodynamic 56 eosinophil count 56 preintervention 56 corrected QT interval 56 neurodevelopmental impairment 56 serum clusterin levels 56 DAS# [002] 56 bladder carcinoma 56 % CI #.#-#.# [005] 56 Reynolds Risk Score 56 serum creatinine levels 56 MMSE 56 baseline HbA1c 56 Natalizumab 56 recurrent miscarriage 56 pulmonary dysfunction 56 dysuria 56 serum thyroglobulin 56 serum uric acid 56 serum ferritin 56 Female Sexual Function 56 nonvertebral fracture 56 protein excretion 56 operable breast cancer 56 prostate cancer PCa 56 neuroleptics 56 apolipoprotein B 56 subsyndromal depression 56 attain statistical significance 56 cerebral infarction 56 schizophrenia schizoaffective disorder 56 p = #.# [003] 56 estrogen receptor ER 56 acute subacute 56 extracapsular extension 56 sensitivity specificity 56 PNH patients 56 Kruskal Wallis test 56 platelet activation 56 attention-deficit/hyperactivity disorder ADHD 56 serum urate levels 56 dysphoric 56 myocardial perfusion 56 negative affectivity 56 oral diclofenac 56 Lumbar spine 56 gait disturbances 56 QT intervals 56 cardiometabolic risk 56 quantitative computed tomography 55 postnatally 55 serum BDNF 55 Kaplan Meier analysis 55 glycated hemoglobin levels 55 CIN2 + 55 thyroid carcinoma 55 plasma homocysteine 55 magnesium intake 55 antipsychotic prescribing 55 hyperintense lesions 55 variance ANOVA 55 Geriatric Depression 55 morphometric vertebral fractures 55 Rating Scale UPDRS 55 preoperative chemotherapy 55 sleeve lobectomy 55 TPMT 55 CIN3 55 spondyloarthritis 55 diabetes mellitus 55 knee arthroplasty 55 chronic pancreatitis 55 akinesia 55 PHQ 9 55 STN stimulation 55 glomerular filtration 55 arterial oxygen saturation 55 Univariate 55 perioperative mortality 55 serum cotinine 55 nonfatal MI 55 systolic BP 55 cortical activation 55 serum homocysteine 55 kidney allograft 55 neurophysiologic 55 dichotomized 55 somatoform disorder 55 asthma exacerbation 55 intravascular hemolysis 55 STRIDE PD 55 neuroleptic 55 oral anticoagulant therapy 55 State Examination MMSE 55 psychosocial distress 55 lactate dehydrogenase 55 hemodynamic measurements 55 hyperparathyroidism 55 elevated IOP 55 explanatory variables 55 ALT AST 55 LDL cholesterol concentrations 55 locoregional 55 malignant neoplasm 55 agomelatine 55 Abnormal Involuntary Movement 55 ovarian hormones 55 Neuroticism 55 Nonspecific 55 urinary bowel 55 endometrial carcinoma 55 Depression Inventory 55 Cronbach alpha 55 atrioventricular block 55 = #.#-#.# 55 pressor response 55 testicular tumors 55 Comorbidities 55 antihypertensive therapy 55 lymphocytosis 55 detrusor 55 inotropes 55 Exclusion criteria 55 acute urinary retention 55 nitrotyrosine 55 hypercalciuria 55 myocardial reperfusion 55 fasting glucose levels 55 testicular germ cell 55 renal allograft 55 duplex ultrasonography 55 hypoglycaemic episodes 55 radical cystectomy 55 fragility fracture 55 eculizumab therapy 55 antimuscarinic 55 Structured Clinical 55 clinically insignificant 55 hydroxyvitamin D concentrations 55 OSAHS 55 microvessel density 55 neuroanatomical 55 ragweed allergic 55 parenchymal 55 urinary albumin 55 rheumatic disease 55 nonadherence 55 genetic polymorphisms 55 Prehypertension 55 seminal vesicle invasion 55 glucose homeostasis 55 socioeconomic status SES 55 peak VO2 55 azoospermia 55 NATRECOR ® 55 PROactive study 55 % CI #.#-#.# [007] 55 HeFH 55 hepatocellular carcinomas 55 cardio metabolic 55 ADHD symptoms 55 syndromic 55 neuropathological 55 prognostic indicator 55 atheroma volume 55 baroreflex sensitivity 55 sd = 55 dyspnea 55 abdominal circumference 55 5 HTTLPR genotype 55 MGUS 55 PCa 55 posterior cingulate 55 menstrual irregularity 55 Prostatitis 55 GH deficient 55 atherothrombotic 55 autoregulation 55 multivariate regression 55 T1a 55 elevated triglycerides 55 androgen excess 55 psychoeducation 55 neuropsychological deficits 55 thromboprophylaxis 55 metabolic disturbances 55 NMIBC 55 MDRD 55 systolic dysfunction 55 LVNC 55 hyperintensities 55 EXJADE 55 Leydig cell 55 multivariable Cox 55 obese adolescents 55 idiopathic intracranial hypertension 55 VLBW 55 serum cholesterol 55 MADRS 55 pulmonary artery banding 55 prostate carcinogenesis